Selectively & Safely Overcoming the Tumour Microenvironment to Reduce Barriers to Solid Tumour CAR-T Success
1:45 pm - Tuesday 9th February 2027
- Understanding solid tumour complexity and their microenvironment to enhance targeting and therapeutic outcomes
- Generating tumour-targeting immune cells tackling heterogeneity and immune suppression to overcome solid tumour defences
- Highlighting the precision and efficacy of HypoxiCAR in delivering highly potent payloads for neuroblastoma elimination
